129 related articles for article (PubMed ID: 36280112)
1. Comments on Dinnoo et al., 2021: ''18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality''.
Yilmaz B; Somay E; Topkan E
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101317. PubMed ID: 36280112
[No Abstract] [Full Text] [Related]
2.
Dinnoo A; Benmoussa N; Bidault F; Brau JJ; Tissot H; Temam S; Janot F; Henry T
J Stomatol Oral Maxillofac Surg; 2022 Sep; 123(4):e192-e198. PubMed ID: 34826634
[TBL] [Abstract][Full Text] [Related]
3. Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol.
Dinnoo A; Bidault F; Lassau N; Elmaalouf M; Moya-Plana A; Ruffier A; Janot F; Benmoussa N
J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):286-287. PubMed ID: 31271892
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
Glicksman JT; Khalili S; Fung K; Parnes LS; Agrawal SK
Head Neck; 2015 Dec; 37(12):E191-3. PubMed ID: 25821165
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in Osteoradionecrosis of the Hyoid.
Antippa SH; Du L; Price N; Hsu CC
Clin Nucl Med; 2021 Jan; 46(1):e49-e50. PubMed ID: 32956123
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
Robard L; Louis MY; Blanchard D; Babin E; Delanian S
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):333-338. PubMed ID: 24993781
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of grade III osteoradionecrosis with mandibular fracture with pentoxifylline, tocopherol and clodronate.
Magremanne M
J Stomatol Oral Maxillofac Surg; 2018 Dec; 119(6):518-522. PubMed ID: 29936237
[TBL] [Abstract][Full Text] [Related]
8. The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
Patel S; Patel N; Sassoon I; Patel V
Radiother Oncol; 2021 Mar; 156():209-216. PubMed ID: 33385466
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
Dissard A; P Dang N; Barthelemy I; Delbet C; Puechmaille M; Depeyre A; Pereira B; Martin F; Guillemin F; Biau J; Mirafzal S; Mom T; Gilain L; Saroul N
Laryngoscope; 2020 Nov; 130(11):E559-E566. PubMed ID: 31747060
[TBL] [Abstract][Full Text] [Related]
10. Protocol for prospective randomised assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline+TOcopherol± CLOdronate for the management of early osteoradionecrosis of the mandible.
Bulsara VM; Bulsara MK; Lewis E
BMJ Open; 2019 Mar; 9(3):e026662. PubMed ID: 30837258
[TBL] [Abstract][Full Text] [Related]
11. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Delanian S; Chatel C; Porcher R; Depondt J; Lefaix JL
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):832-9. PubMed ID: 20638190
[TBL] [Abstract][Full Text] [Related]
12. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
Rivero JA; Shamji O; Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):464-471. PubMed ID: 29103566
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of osteoradionecrosis associated with periodontitis using
Ito K; Takumi K; Meibom SK; Qureshi MM; Fujima N; Andreu-Arasa VC; Truong MT; Salama AR; Kaneda T; Sakai O
Eur J Radiol; 2020 Nov; 132():109259. PubMed ID: 33012550
[TBL] [Abstract][Full Text] [Related]
14. 18F FDG Uptake Due to Late-Onset Osteoradionecrosis for Tongue Base Carcinoma.
Dholam KP; Singh GP; Agarwal JP; Mahajan A
Clin Nucl Med; 2019 May; 44(5):e345-e346. PubMed ID: 30789393
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
Martos-Fernández M; Saez-Barba M; López-López J; Estrugo-Devesa A; Balibrea-Del-Castillo JM; Bescós-Atín C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):431-439. PubMed ID: 29550081
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients.
Meerwein CM; Nakadate M; Stolzmann P; Vital D; Morand GB; Zweifel DF; Huber GF; Huellner MW
Clin Otolaryngol; 2018 Dec; 43(6):1594-1599. PubMed ID: 29974995
[No Abstract] [Full Text] [Related]
17. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
Kim Y; Lee HY; Yoon HJ; Kim BS
J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review.
Banjar A; Patel V; Abed H
Oral Dis; 2023 Jan; 29(1):29-39. PubMed ID: 34695271
[TBL] [Abstract][Full Text] [Related]
19. Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Lee JA; Huh SJ; Oh D; Bae DS
Ann Nucl Med; 2008 Feb; 22(2):139-41. PubMed ID: 18311539
[TBL] [Abstract][Full Text] [Related]
20. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
